Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil + propofol TCI: controlled vs spontaneous ventilation
2005-004479-38Phase 3Completed
- Sponsor
- Papa Giovanni XXIII Hospital
- Start
- Sep 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of remifentanil and propofol in general anesthesia (2 arms), sponsored by Papa Giovanni XXIII Hospital. Primary endpoint: Effects on respiratory gas exchange. Started Sep 2007; status: completed.
02
Drugs
remifentanilpropofol
03
Conditions
general anesthesia
Beyond the preview
Go deeper on 2005-004479-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004479-38.